{
  "@context": {
    "@vocab": "http://schema.org/",
    "rdau": "http://rdaregistry.info/Elements/u/",
    "skos": "http://www.w3.org/2004/02/skos/core#",
    "skos:prefLabel": {
      "@container": "@language"
    }
  },
  "@graph": [
    {
      "@id": "http://www.yso.fi/onto/yso/p22961",
      "name": "valproaatti"
    },
    {
      "@id": "http://urn.fi/URN:NBN:fi:bib:me:W01118623100",
      "about": {
        "@id": "http://www.yso.fi/onto/yso/p22961"
      },
      "name": [
        "Antiepileptic drug treatment in the elderly :",
        "Choice of initial treatment, potential interactions and seizure outcome",
        "Antiepileptic drug treatment in the elderly : choice of initial treatment, potential interactions and seizure outcome"
      ]
    },
    {
      "@id": "http://urn.fi/URN:NBN:fi:bib:me:W00532146200",
      "about": {
        "@id": "http://www.yso.fi/onto/yso/p22961"
      },
      "name": "Insulin-related metabolic and endocrine effects of valproate in patients with epilepsy"
    },
    {
      "@id": "http://urn.fi/URN:NBN:fi:bib:me:W00701899100",
      "about": {
        "@id": "http://www.yso.fi/onto/yso/p22961"
      },
      "name": "Disturbances in mitochondrial DNA maintenance in neuromuscular disorders and valproate-induced liver toxicity"
    }
  ]
}